July 1, 2013 | Over the weekend, Onyx Pharmaceuticals stirred up speculation over a buyout. Amgen reportedly offered $120/share, and Onyx responded by issuing a call for other suitors. This morning, pundits speculate that the price could hit $180/share. Forbes